Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system

Kannan Sridharan, Gowri Sivaramakrishnan

Open source

DOI
10.1016/j.pedneo.2026.06.013
Published
2026-10
Container
Pediatrics & Neonatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pedneo.2026.06.013,
  title = {Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system},
  author = {Kannan Sridharan and Gowri Sivaramakrishnan},
  year = {2026},
  journal = {Pediatrics \& Neonatology},
  doi = {10.1016/j.pedneo.2026.06.013},
  url = {https://doi.org/10.1016/j.pedneo.2026.06.013}
}

RIS

TY  - JOUR
TI  - Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system
AU  - Kannan Sridharan
AU  - Gowri Sivaramakrishnan
PY  - 2026
JO  - Pediatrics & Neonatology
DO  - 10.1016/j.pedneo.2026.06.013
UR  - https://doi.org/10.1016/j.pedneo.2026.06.013
ER  - 

APA

Sridharan, K., & Sivaramakrishnan, G. (2026). Drug-associated severe cutaneous adverse events in infants: Results of a disproportionality analysis from the USFDA adverse event reporting system. Pediatrics & Neonatology. https://doi.org/10.1016/j.pedneo.2026.06.013

Source records